MARKETOCRACY FUNDS
NSAR-B, EX-27, 2000-08-23
Previous: MARKETOCRACY FUNDS, NSAR-B, 2000-08-23
Next: MARKETOCRACY FUNDS, NSAR-B, EX-99, 2000-08-23



<TABLE> <S> <C>


<ARTICLE>                                             6
<CIK>   0001090154
<NAME>  MARKETOCRACY MEDICAL SPECIALISTS FUND
<MULTIPLIER>                                   1

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              JUN-30-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<INVESTMENTS-AT-COST>                           42,249,027
<INVESTMENTS-AT-VALUE>                          46,912,995
<RECEIVABLES>                                       62,863
<ASSETS-OTHER>                                          50
<OTHER-ITEMS-ASSETS>                                     0
<TOTAL-ASSETS>                                  46,975,908
<PAYABLE-FOR-SECURITIES>                                 0
<SENIOR-LONG-TERM-DEBT>                                  0
<OTHER-ITEMS-LIABILITIES>                         (90,921)
<TOTAL-LIABILITIES>                               (90,921)
<SENIOR-EQUITY>                                          0
<PAID-IN-CAPITAL-COMMON>                        42,302,399
<SHARES-COMMON-STOCK>                            2,787,407
<SHARES-COMMON-PRIOR>                            1,168,765
<ACCUMULATED-NII-CURRENT>                                0
<OVERDISTRIBUTION-NII>                                   0
<ACCUMULATED-NET-GAINS>                           (81,380)
<OVERDISTRIBUTION-GAINS>                                 0
<ACCUM-APPREC-OR-DEPREC>                         4,663,968
<NET-ASSETS>                                    46,884,987
<DIVIDEND-INCOME>                                   44,613
<INTEREST-INCOME>                                   89,278
<OTHER-INCOME>                                           0
<EXPENSES-NET>                                   (412,352)
<NET-INVESTMENT-INCOME>                          (278,461)
<REALIZED-GAINS-CURRENT>                           219,939
<APPREC-INCREASE-CURRENT>                        1,879,921
<NET-CHANGE-FROM-OPS>                            1,821,399
<EQUALIZATION>                                           0
<DISTRIBUTIONS-OF-INCOME>                                0
<DISTRIBUTIONS-OF-GAINS>                                 0
<DISTRIBUTIONS-OTHER>                                    0
<NUMBER-OF-SHARES-SOLD>                          3,234,086
<NUMBER-OF-SHARES-REDEEMED>                    (1,615,444)
<SHARES-REINVESTED>                                      0
<NET-CHANGE-IN-ASSETS>                          30,327,220
<ACCUMULATED-NII-PRIOR>                                  0
<ACCUMULATED-GAINS-PRIOR>                         (22,858)
<OVERDISTRIB-NII-PRIOR>                                  0
<OVERDIST-NET-GAINS-PRIOR>                               0
<GROSS-ADVISORY-FEES>                            (317,194)
<INTEREST-EXPENSE>                                       0
<GROSS-EXPENSE>                                  (412,352)
<AVERAGE-NET-ASSETS>                            42,374,595
<PER-SHARE-NAV-BEGIN>                                14.17
<PER-SHARE-NII>                                     (0.10)
<PER-SHARE-GAIN-APPREC>                               2.75
<PER-SHARE-DIVIDEND>                                     0
<PER-SHARE-DISTRIBUTIONS>                             0.00
<RETURNS-OF-CAPITAL>                                     0
<PER-SHARE-NAV-END>                                  16.82
<EXPENSE-RATIO>                                       1.95



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission